LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $30
Jefferies Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $28 to $37
Analysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Kura Oncology (KURA)
Kura Oncology Analyst Ratings
BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Announces Target Price $29
Barclays Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $32
BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Cooper Co (COO) and Ironwood Pharma (IRWD)
Jefferies Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28
Jefferies Sticks to Its Buy Rating for Kura Oncology (KURA)
Stifel Maintains Kura Oncology(KURA.US) With Hold Rating, Cuts Target Price to $11
Stifel Nicolaus Keeps Their Hold Rating on Kura Oncology (KURA)
Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), Bruker (BRKR)
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $18 to $34
Kura Oncology Analyst Ratings
Kura Oncology's Strategic Developments and Partnership With Kyowa Kirin Justify Buy Rating, Despite Initial Stock Dip
Barclays Reaffirms Their Buy Rating on Kura Oncology (KURA)
Kura Oncology Is Maintained at Buy by Jefferies
Kura Oncology (KURA) Receives a Buy From Wedbush